Crohn's disease: A gastrointestinal disorder characterized by chronic inflammation involving all layers of the intestinal wall, noncaseating granulomas affecting the intestinal wall and regional lymph nodes, and transmural fibrosis. Crohn disease most commonly involves the terminal ileum; the colon is the second most common site of involvement.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1638 |
4. Check minimum number of eventsNone |
1638 |
5. Include endpointsNone |
1638 |
6. Filter based on genotype QC (FinnGen only) |
1638 |
Control definitions (FinnGen only)
- Control exclude
- K11_ENERCOLNONINF
Extra metadata
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- K51
- Name in latin
- Ileocolitis ulcerosa [chronica]
Similar endpoints
↥List of similar endpoints to
Ulcerative ileocolitis
based on the number of shared cases.
Similar with more cases:
- Ulcerative colitis
- Inflammatory bowel disease
- Noninfective enteritis and colitis
- Autoimmune diseases related-to ILD
- Autoimmune diseases
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 7929 | 3602 | 4295 |
| Only index persons | 7575 | 3493 | 4082 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.11 | 0.10 | 0.12 |
| Only index persons | 0.14 | 0.13 | 0.16 |
| Median age at first event (years) | |||
| Whole population | 41.83 | 40.60 | 42.72 |
| Only index persons | 41.12 | 40.19 | 41.92 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1638 | 856 | 782 |
| Unadjusted period prevalence (%) | 0.32 | 0.29 | 0.34 |
| Median age at first event (years) | 42.23 | 39.28 | 45.47 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1519
- Matched controls
- 15191
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K51.8
ICD-10 Finland
Other ulcerative colitis
+∞
323.0
470
*
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
1289.2
323.0
309
*
UJF32
NOMESCO Finland
Coloscopy
41.7
323.0
1271
1662
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
+∞
323.0
636
*
K51.5
ICD-10 Finland
Left sided colitis
4503599627370496.0
323.0
1172
*
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
+∞
323.0
1412
*
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
+∞
323.0
307
*
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
+∞
323.0
344
*
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
6344.7
323.0
1030
5
A07EC02
ATC
mesalazine; oral, rectal
2660.0
323.0
1372
53
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
+∞
323.0
1515
*
H02AB06
ATC
prednisolone; systemic
13.7
323.0
1292
4457
UJF30
NOMESCO Finland
Ileoscopy through colon
30.3
323.0
745
468
K50.1
ICD-10 Finland
Crohn disease of large intestine
+∞
323.0
305
*
A07EA02
ATC
hydrocortisone; rectal
509.7
323.0
694
25
A07EA06
ATC
budesonide; oral, local oral
351.0
323.0
571
26
L04AX01
ATC
azathioprine; systemic
187.2
323.0
929
127
K50.8
ICD-10 Finland
Other Crohn disease
3325.5
305.7
285
*
K51
ICD-10 Finland
Ulcerative colitis
1690.5
294.6
277
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
7.3
260.3
827
2126
H02AB07
ATC
prednisone; oral
9.5
247.7
587
946
K50.9
ICD-10 Finland
Crohn disease, unspecified
+∞
241.2
225
*
A07EC01
ATC
sulfasalazine; oral, rectal
12.0
231.4
462
533
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
12.9
230.4
442
469
L01BB02
ATC
mercaptopurine; oral
237.2
221.1
223
11
K50.0
ICD-10 Finland
Crohn disease of small intestine
+∞
211.5
198
*
J01MA02
ATC
ciprofloxacin; systemic
5.3
198.0
936
3535
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
+∞
196.2
184
*
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
+∞
188.5
177
*
P01AB01
ATC
metronidazole; oral, rectal
5.0
187.7
956
3827
D94
ICPC
Chronic enteritis/ulcerative colitis
2012.4
179.8
171
*
A07EA01
ATC
prednisolone; rectal
446.2
163.8
161
*
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
50.4
160.4
194
44
ZX120
NOMESCO Finland
Intravenous
8.1
153.5
382
605
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
1553.2
146.3
140
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
4.6
145.3
656
2144
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
101.7
134.8
147
16
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
+∞
134.4
127
*
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
100.3
125.4
137
15
M07.5*K51.9
ICD-10 Finland
Arthropathy in ulcerative colitis
+∞
118.3
112
*
K83.0
ICD-10 Finland
Cholangitis
44.8
118.1
146
36
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
+∞
116.1
110
*
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
90.8
113.1
125
15
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.9
108.2
230
269
TPH04
NOMESCO Finland
Cathetrisation of vein
4.2
105.8
493
1564
5561A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
+∞
95.9
91
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
16.9
95.6
156
102
4AA12
NOMESCO Finland
NA
492.3
94.4
93
*
WX002
NOMESCO Finland
Sedation and analgesia
4.0
92.6
453
1473
A05AA02
ATC
ursodeoxycholic acid; oral
20.9
90.2
136
71
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
5.5
85.0
279
601
A07EC03
ATC
olsalazine; oral
+∞
84.1
80
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.0
83.2
742
3713
H02AB09
ATC
hydrocortisone; systemic
15.3
82.7
140
100
A02BC02
ATC
pantoprazole; systemic
3.0
82.5
1078
6871
5568X
ICD-9 Finland
Idiopathic proctocolitis, Other ulcerative colitis
+∞
82.0
78
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
3.7
80.1
419
1416
JFH10
NOMESCO Finland
Total colectomy and ileostomy
270.3
76.2
77
*
L04AB04
ATC
adalimumab; parenteral
14.0
73.5
129
100
JFH33
NOMESCO Finland
Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy
+∞
72.5
69
*
JFF10
NOMESCO Finland
Loop enterostomy
59.2
71.6
84
15
JGB50
NOMESCO Finland
Mucosal proctectomy and ileoanal anastomosis
+∞
71.4
68
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
8.3
70.8
164
217
JKE98
NOMESCO Finland
Other transduodenal endoscopic operation on bile duct or ampulla of Vater
22.2
69.3
102
49
4AB02
NOMESCO Finland
NA
125.9
67.5
72
6
L04AD01
ATC
ciclosporin; systemic
13.8
67.5
119
93
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.3
65.9
272
732
UJF92
NOMESCO Finland
Capsular endoscopy
16.3
59.8
98
64
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
5.7
59.4
183
358
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
54.4
510
2459
A06AC01
ATC
ispaghula (psylla seeds); oral
2.8
53.2
408
1740
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
16.5
52.9
86
55
A07DA03
ATC
loperamide; oral
7.8
52.6
126
174
Z93.2
ICD-10 Finland
Ileostomy status
76.8
52.4
59
8
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
3.7
51.4
252
779
J01MA12
ATC
levofloxacin; systemic
3.0
50.5
335
1297
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.7
49.7
239
725
C10AC01
ATC
colestyramine; oral
10.5
49.1
98
99
N02AX02
ATC
tramadol; systemic, rectal
2.3
47.3
676
3977
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
13.5
46.5
82
64
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
49.8
44.1
53
11
K50
ICD-10 Finland
Crohn disease [regional enteritis]
+∞
44.0
42
*
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.6
43.7
214
655
WVA20
NOMESCO Finland
Medicine administration
9.4
43.6
92
103
K56.7
ICD-10 Finland
Ileus, unspecified
16.1
43.5
71
46
1370
FHL
Colonoscopy, whole colon
48.9
43.1
52
11
JFH11
NOMESCO Finland
Laparoscopic colectomy
+∞
42.9
41
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.1
42.1
259
941
M07.5
ICD-10 Finland
Arthropathy in ulcerative colitis
+∞
41.9
40
*
JL5SB
NOMESCO Finland
Endoscopic retrograd cholangiopancreaticography
15.8
41.3
68
45
WX402
NOMESCO Finland
General anaesthesia
2.7
41.0
329
1416
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
55.0
40.7
48
9
JF1BD
NOMESCO Finland
Very extensive small bowel CT
53.8
39.7
47
9
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
39.7
602
3559
3AC01
NOMESCO Finland
NA
15.4
39.1
65
44
JFF13
NOMESCO Finland
Terminal enterostomy
88.5
39.0
43
5
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
+∞
38.7
37
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
16.0
38.5
63
41
JF2AB
NOMESCO Finland
Colongraphy with X-ray
44.0
38.3
47
11
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
4.9
38.3
132
290
UJK12
NOMESCO Finland
Peroral cholangioscopy
64.7
38.3
44
7
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
7.5
37.8
92
130
UJK02
NOMESCO Finland
ERCP
9.0
37.1
80
93
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
36.3
368
1786
4AA33
NOMESCO Finland
NA
+∞
35.6
34
*
JFG73
NOMESCO Finland
Excision of ileal pelvic pouch
+∞
35.6
34
*
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
9.3
35.1
74
83
R50.9
ICD-10 Finland
Fever, unspecified
2.7
34.3
263
1090
JN3AD
NOMESCO Finland
Abdominal CT examination
3.7
34.1
159
464
B01AB05
ATC
enoxaparin; parenteral
2.2
33.6
448
2457
Z93
ICD-10 Finland
Artificial opening status
51.3
33.6
40
8
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
15.4
33.3
55
37
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.6
32.5
78
108
M09.2*K51.9
ICD-10 Finland
Juvenile arthritis in ulcerative colitis
+∞
32.4
31
*
UJG02
NOMESCO Finland
Proctoscopy
8.9
32.4
70
82
K60.3
ICD-10 Finland
Anal fistula
7.8
32.3
76
102
A02BC01
ATC
omeprazole; systemic
2.2
32.2
425
2317
L04AA01
ATC
[U] ciclosporin; systemic
10.6
32.1
63
62
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
48.6
31.7
38
8
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
32.4
31.4
41
13
JHA00
NOMESCO Finland
Anal or perianal incision
9.3
31.3
66
74
JFH20
NOMESCO Finland
Proctocolectomy and ileostomy
308.3
29.9
30
*
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.9
29.8
130
358
JAH00
NOMESCO Finland
Laparotomy
7.4
29.8
72
101
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
15.3
29.7
49
33
L04AC05
ATC
ustekinumab; parenteral
37.9
29.4
37
10
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.3
29.0
79
131
K51.4
ICD-10 Finland
Inflammatory polyps
+∞
28.2
27
*
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
65.3
28.0
32
5
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
7.7
27.3
64
86
5560A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis
+∞
27.2
26
*
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
4.7
26.8
94
210
JHD00
NOMESCO Finland
Anal dilatation
15.8
26.5
43
28
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
4.6
25.8
92
209
B01AB10
ATC
tinzaparin; parenteral
3.4
25.8
130
403
A07AA09
ATC
vancomycin; oral
12.5
25.1
45
37
L04AB06
ATC
golimumab; parenteral
14.4
24.9
42
30
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.6
24.8
192
791
SPAT1262
SPAT
Handing over of treatment supplies
2.3
24.6
268
1318
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
57.0
24.1
28
5
3042
Kela drug reimbursment
NA
+∞
24.0
23
*
253
Kela drug reimbursment
NA
+∞
24.0
23
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.7
24.0
84
188
JL5BG
NOMESCO Finland
MRI examinaiton of bile and pancreas ducts with high intesity magnet
6.5
23.8
63
101
A02BC05
ATC
esomeprazole; systemic
1.8
23.6
580
3892
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
4.4
23.3
86
203
JFB00
NOMESCO Finland
Partial resection of small intestine
8.2
22.8
51
64
B03BA03
ATC
hydroxocobalamin; parenteral
4.4
22.6
85
204
K92.1
ICD-10 Finland
Melaena
4.2
22.6
88
219
TJJ00
NOMESCO Finland
Percutaneous needle biopsy of liver
45.7
22.4
27
6
Z94.4
ICD-10 Finland
Liver transplant status
52.8
22.1
26
5
6419
FHL
Other measure in this category
223.1
21.6
22
*
K61.0
ICD-10 Finland
Anal abscess
6.3
21.6
58
95
J01DB01
ATC
cefalexin; oral
1.8
21.2
1219
10442
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.4
21.1
105
323
TJF80
NOMESCO Finland
Ostomy education
13.6
21.0
36
27
JFG50
NOMESCO Finland
Laparotomy with revision of enterostomy or colostomy
+∞
20.9
20
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
20.7
319
1807
E86
ICD-10 Finland
Volume depletion
6.7
20.7
53
82
C05AA08
ATC
fluocortolone; rectal, topical
2.2
20.3
222
1087
N02BE01
ATC
paracetamol; systemic, rectal
1.8
20.2
1242
10758
1490
FHL
Sigmoideoscopy (fiberscope)
36.3
19.9
25
7
K73.2
ICD-10 Finland
Chronic active hepatitis, not elsewhere classified
36.3
19.9
25
7
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.1
19.8
263
1400
JHW96
NOMESCO Finland
Other operation on anus or perianal tissue
18.0
19.6
30
17
M05BA04
ATC
alendronic acid; oral
3.3
19.3
99
312
3005
Kela drug reimbursment
Tofacitinib
34.8
18.9
24
7
K62.8
ICD-10 Finland
Other specified diseases of anus and rectum
13.6
18.8
32
24
H02AB04
ATC
methylprednisolone; systemic
2.1
18.7
220
1110
JFA38
NOMESCO Finland
Endoscopic dilatation of small intestine
192.3
18.6
19
*
UJD02
NOMESCO Finland
Gastroscopy
3.6
18.5
84
240
UJF34
NOMESCO Finland
Left colonoscopy
15.3
18.5
30
20
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.3
18.2
188
895
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
18.1
117
430
JHD33
NOMESCO Finland
Completing incision of fistula-in-ano
53.2
18.0
21
*
N03AX16
ATC
pregabalin; oral
1.9
17.9
324
1931
K56.0
ICD-10 Finland
Paralytic ileus
12.1
17.8
32
27
JJC00
NOMESCO Finland
Allogenic transplantation of liver
67.4
17.7
20
*
K76.9
ICD-10 Finland
Liver disease, unspecified
7.6
17.7
41
55
JFA70
NOMESCO Finland
Suture of small intestine
29.2
17.4
23
8
ZXC86
NOMESCO Finland
Use of endoscopic device
17.2
17.4
27
16
A02BC03
ATC
lansoprazole; oral
1.8
17.3
381
2420
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.4
17.3
63
148
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
8.5
16.7
36
43
5551A
ICD-9 Finland
Regional enteritis, Large intestine
+∞
16.7
16
*
5586X
ICD-9 Finland
Other non-infective gastro-enteritis and colitis[KROONINEN INFLAMMATOORINEN SUOLISTOSAIRAUS, NUD]
+∞
16.7
16
*
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
35.5
16.7
21
6
A03CA02
ATC
clidinium and psycholeptics; oral
3.4
16.0
78
237
E0000UV
ATC
NA
1.6
15.8
547
3933
RD210
NOMESCO Finland
NA
5.3
15.8
48
93
JL5CG
NOMESCO Finland
Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet
10.5
15.7
30
29
JGB40
NOMESCO Finland
Excision of rectum and end ileostomy
+∞
15.6
15
*
56399
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Other
+∞
15.6
15
*
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
5.8
15.6
44
78
JFH00
NOMESCO Finland
Total colectomy and ileorectal anastomosis
86.0
15.6
17
*
K83.9
ICD-10 Finland
Disease of biliary tract, unspecified
19.4
15.6
23
12
JWW96
NOMESCO Finland
Other reoperation in gastroenterological surgery
161.6
15.5
16
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
15.4
140
624
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.9
15.3
97
351
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.4
15.3
134
588
A07AA02
ATC
nystatin; oral
3.2
15.3
82
268
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.6
15.2
586
4318
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.4
15.2
133
580
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.8
15.2
272
1607
M13.9
ICD-10 Finland
Arthritis, unspecified
2.6
15.1
115
467
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.8
15.0
97
359
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
6.6
15.0
38
59
UJF02
NOMESCO Finland
Peroral enteroscopy
15.2
14.9
24
16
WW200
NOMESCO Finland
Immunization
3.8
14.9
64
176
M07.4
ICD-10 Finland
Arthropathy in Crohn disease [regional enteritis]
+∞
14.6
14
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.8
14.5
257
1510
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
14.5
104
409
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
14.3
643
4898
0093A
ICD-9 Finland
Ill-defined intestinal infections, Diarrhoea of presumed infectious origin
6.2
14.3
38
63
B81
ICPC
Anaemia vit B12/folate deficiency
4.2
14.2
54
133
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.6
14.2
458
3213
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.3
14.1
135
620
JKE02
NOMESCO Finland
Transduodenal endoscopic incision of common bile duct orifice
7.6
13.9
32
43
D06BX01
ATC
metronidazole; topical
2.1
13.9
156
770
K83.8
ICD-10 Finland
Other specified diseases of biliary tract
53.8
13.8
16
*
WX110
NOMESCO Finland
Local anesthesy
1.5
13.7
1017
8638
K29.3
ICD-10 Finland
Chronic superficial gastritis
4.4
13.6
49
115
56300
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Regional enteritis
+∞
13.6
13
*
5761C
ICD-9 Finland
Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]
+∞
13.6
13
*
D64.9
ICD-10 Finland
Anaemia, unspecified
2.5
13.5
106
440
R4110
NOMESCO Finland
Physiotherapy
1.7
13.4
345
2272
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
2.4
13.3
111
476
K85
ICD-10 Finland
Acute pancreatitis
6.2
13.2
35
58
D07AC01
ATC
betamethasone; topical
1.6
13.0
451
3209
JKE32
NOMESCO Finland
Endoscopic dilatation of bile duct
28.6
13.0
17
6
K62.4
ICD-10 Finland
Stenosis of anus and rectum
22.7
12.9
18
8
K83.1
ICD-10 Finland
Obstruction of bile duct
7.8
12.9
29
38
JJ1LE
NOMESCO Finland
Ultrasound elastography of liver
8.6
12.8
27
32
R11
ICD-10 Finland
Nausea and vomiting
2.4
12.7
113
501
D18
ICPC
Change in faeces/bowel movements
4.6
12.6
43
96
N02AJ06
ATC
codeine and paracetamol; systemic
1.5
12.6
520
3852
56902
ICD-8 Finland
Other diseases of intestines and peritoneum, Proctitis haemorrhagica (ulcerosa)
+∞
12.5
12
*
6410
FHL
Panprococolectomy and ileostomy
+∞
12.5
12
*
L04AA29
ATC
tofacitinib; oral
20.2
12.5
18
9
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
3.1
12.4
69
232
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.2
12.4
132
634
JF1AD
NOMESCO Finland
Small bowel CT
11.7
12.3
22
19
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.8
12.2
214
1249
JJ9AE
NOMESCO Finland
Ultrasound examination of liver transplant
37.9
12.2
15
*
R4190
NOMESCO Finland
Nutritional therapy
3.5
12.2
56
164
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
4.5
12.2
42
95
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
18.2
12.1
18
10
WX600
NOMESCO Finland
Single shot through catheter
4.1
12.0
46
115
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
6.9
11.9
29
43
A07AA11
ATC
rifaximin; oral
47.0
11.9
14
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
11.8
106
470
N11.9
ICD-10 Finland
Chronic tubulo-interstitial nephritis, unspecified
14.8
11.8
19
13
A02BA02
ATC
ranitidine; systemic
1.8
11.7
225
1355
K74.3
ICD-10 Finland
Primary biliary cirrhosis
12.6
11.6
20
16
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.5
11.6
54
160
K73.9
ICD-10 Finland
Chronic hepatitis, unspecified
19.1
11.6
17
9
JHD30
NOMESCO Finland
Incomplete incision of fistula-in-ano
19.1
11.6
17
9
J02AC01
ATC
fluconazole; systemic
1.5
11.6
546
4143
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.9
11.5
68
239
L04AA33
ATC
vedolizumab; parenteral
+∞
11.5
11
*
5552A
ICD-9 Finland
Regional enteritis, Small intestine with large intestine
+∞
11.5
11
*
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
15.2
11.3
18
12
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
4.7
11.2
37
80
J05AB11
ATC
valaciclovir; oral
1.9
11.1
173
968
S02.51
ICD-10 Finland
Fracture of tooth, open
2.0
11.0
148
783
K59.1
ICD-10 Finland
Functional diarrhoea
3.0
10.9
63
218
-44
ICPC
Preventive immunization/medic
2.3
10.8
105
485
6525
FHL
Enterostomy occlusion
60.4
10.6
12
*
JKD20
NOMESCO Finland
Anastomosis of bile duct to jejunum
60.4
10.6
12
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.2
10.6
109
518
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
11.3
10.6
19
17
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.4
10.5
49
146
JFA76
NOMESCO Finland
Closure of fistula of small intestine
110.8
10.4
11
*
JF1CM
NOMESCO Finland
Small bowel extensive MRI with with high intensity magnet
110.8
10.4
11
*
JF1DM
NOMESCO Finland
Very extensive MRI of small bowel (more than 1.5 T)
+∞
10.4
10
*
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
10.3
184
1080
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
18.9
10.3
15
8
UJH02
NOMESCO Finland
Anoscopy
2.7
10.2
66
247
S18
ICPC
Laceration/cut
1.5
10.1
513
3926
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
4.0
10.0
39
100
Z93.3
ICD-10 Finland
Colostomy status
9.2
10.0
20
22
SPAT1324
SPAT
Screening procedure
0.5
10.0
97
1750
K75.9
ICD-10 Finland
Inflammatory liver disease, unspecified
6.1
10.0
26
43
JHD20
NOMESCO Finland
Incision of fistula-in-ano
5.8
10.0
27
47
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
40.3
10.0
12
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.6
9.9
71
282
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.2
9.9
96
443
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.6
9.9
73
293
L88
ICD-10 Finland
Pyoderma gangrenosum
16.8
9.9
15
9
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
2.8
9.7
61
223
M45
ICD-10 Finland
Ankylosing spondylitis
3.3
9.7
47
145
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.0
9.7
124
648
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.3
9.6
89
404
XJW99
NOMESCO Finland
Other investigative procedure on digestive system
11.4
9.6
17
15
H20.1
ICD-10 Finland
Chronic iridocyclitis
5.5
9.5
27
50
R01AD12
ATC
fluticasone furoate; nasal
1.5
9.5
430
3209
M81.4
ICD-10 Finland
Drug-induced osteoporosis
17.6
9.4
14
8
JN4BD
NOMESCO Finland
Extensive body CT
2.0
9.4
124
655
K52.80
ICD-10 Finland
(Hemorrhagic) colitis caused by antibiotics
+∞
9.4
9
*
JWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery
+∞
9.4
9
*
5550A
ICD-9 Finland
Regional enteritis, Small intestine
+∞
9.4
9
*
D50.8
ICD-10 Finland
Other iron deficiency anaemias
5.4
9.4
27
51
D07AC13
ATC
mometasone; topical
1.5
9.4
376
2730
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
8.1
9.3
20
25
OAB74
NOMESCO Finland
Nutritional guidance related to treatment and rehabilitation for medical condition
8.1
9.3
20
25
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
8.1
9.3
20
25
J01FA10
ATC
azithromycin; systemic
1.4
9.3
821
6937
J05AB01
ATC
aciclovir; systemic
1.6
9.2
267
1799
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.4
9.2
837
7104
K61.1
ICD-10 Finland
Rectal abscess
13.8
9.2
15
11
Z01.2
ICD-10 Finland
Dental examination
1.4
9.2
572
4537
M01AE01
ATC
ibuprofen; systemic, rectal
0.7
9.2
1148
12490
-1
SPAT
NA
2.7
9.1
61
231
S01FA04
ATC
cyclopentolate; ophthalmic
5.4
9.1
26
49
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.6
9.1
39
110
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
2.3
8.9
79
348
N05CF01
ATC
zopiclone; oral
1.5
8.9
376
2758
WW500
NOMESCO Finland
Blood transfusion
2.9
8.9
53
189
-69
ICPC
Other reason for encounter NEC
2.8
8.9
56
206
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
8.8
293
2038
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
8.7
8.8
18
21
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.5
8.7
289
2010
JFF11
NOMESCO Finland
Laparoscopic loop enterostomy
14.1
8.7
14
10
JFB20
NOMESCO Finland
Ileocaecal resection
14.1
8.7
14
10
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
8.7
116
614
K91.8
ICD-10 Finland
Other postprocedural disorders of digestive system, not elsewhere classified
50.3
8.7
10
*
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
8.6
634
5159
WX723
NOMESCO Finland
CPAP therapy
2.6
8.6
60
236
M46.1
ICD-10 Finland
Sacroiliitis, not elsewhere classified
4.4
8.4
29
67
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
8.4
928
8083
K63.2
ICD-10 Finland
Fistula of intestine
90.5
8.4
9
*
Z90.4
ICD-10 Finland
Acquired absence of other parts of digestive tract
90.5
8.4
9
*
JN1DM
NOMESCO Finland
Upper part of abdomen very extensive MRI examination with 3 Tesla magnet
90.5
8.4
9
*
B02.9
ICD-10 Finland
Zoster without complication
2.5
8.4
65
271
127
Kela drug reimbursment
Transplant complication
3.7
8.4
35
97
JFH31
NOMESCO Finland
Laparoscopic total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
+∞
8.3
8
*
5589X
ICD-9 Finland
Other non-infective gastro-enteritis and colitis, Other and unspecified non-infectious gastro-enteritis and colitis
+∞
8.3
8
*
4AC05
NOMESCO Finland
NA
+∞
8.3
8
*
D07AD01
ATC
clobetasol; topical
1.7
8.3
191
1209
K30
ICD-10 Finland
Functional dyspepsia
1.8
8.3
134
761
A01AB09
ATC
miconazole; local oral
2.0
8.3
97
490
J01DA01
ATC
[U] cefalexin; systemic
1.4
8.2
856
7375
R15
ICD-10 Finland
Faecal incontinence
3.9
8.2
32
84
M25.5
ICD-10 Finland
Pain in joint
1.5
8.1
362
2678
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
8.2
8.1
17
21
NA6AA
NOMESCO Finland
Sacro-iliac joint X-ray examination
8.2
8.1
17
21
JFK00
NOMESCO Finland
Division of adhesive band in intestinal obstruction
33.5
8.1
10
*
K55.9
ICD-10 Finland
Vascular disorder of intestine, unspecified
17.3
8.1
12
7
L04AA06
ATC
mycophenolic acid; systemic
3.3
8.1
38
116
J45.9
ICD-10 Finland
Asthma, unspecified
1.6
8.0
211
1385
5604
FHL
Vascular preparation or cannulation in the operating room
22.1
8.0
11
5
Z43.2
ICD-10 Finland
Attention to ileostomy
22.1
8.0
11
5
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.7
8.0
162
987
JG1JB
NOMESCO Finland
Defekography with X-ray
7.3
8.0
18
25
R74.0
ICD-10 Finland
Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]
3.9
8.0
31
81
L40.0
ICD-10 Finland
Psoriasis vulgaris
2.4
7.9
65
280
SPAT1263
SPAT
Sampling
1.4
7.9
532
4249
N06AA09
ATC
amitriptyline; systemic
1.9
7.9
114
624
M81.9
ICD-10 Finland
Osteoporosis, unspecified
3.3
7.9
37
113
K80.3
ICD-10 Finland
Calculus of bile duct with cholangitis
8.5
7.8
16
19
S29
ICPC
Skin symptom/complaint other
1.6
7.7
197
1281
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.8
7.7
47
172
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
4.4
7.6
26
60
D07AB08
ATC
desonide; topical
1.8
7.6
139
821
JN3DE
NOMESCO Finland
Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation
11.9
7.6
13
11
TAB24
NOMESCO Finland
Implantation of epidural injection gate
25.1
7.6
10
*
D11
ICPC
Diarrhoea
1.7
7.5
153
934
D07XC01
ATC
betamethasone, combinations; topical
1.7
7.5
146
880
A02BA03
ATC
famotidine; systemic
2.9
7.5
44
157
R05
ICD-10 Finland
Cough
1.6
7.4
222
1499
WX419
NOMESCO Finland
Other general anesthesy
4.2
7.4
26
62
SPAT1125
SPAT
Stoma care and guidance
5.3
7.4
21
40
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.5
7.4
55
225
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
7.4
492
3913
D70.89
ICD-10 Finland
Neutropenic splenomegaly
4.7
7.3
23
49
K45.8
ICD-10 Finland
Other specified abdominal hernia without obstruction or gangrene
10.9
7.3
13
12
JFH01
NOMESCO Finland
Laparoscopic colectomy with ileorectal anastomosis
+∞
7.3
7
*
5563A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctosigmoiditis
+∞
7.3
7
*
M09.1*K50.9
ICD-10 Finland
Juvenile arthritis in Crohn's disease [regional enteritis]
+∞
7.3
7
*
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
+∞
7.3
7
*
6408
FHL
Colectomy and ileostomy
+∞
7.3
7
*
A41.9
ICD-10 Finland
Sepsis, unspecified
2.8
7.3
43
154
RS221
NOMESCO Finland
NA
3.9
7.3
28
73
1300
FHL
Esophagogastroduodenoscopy (also includes staining)
6.3
7.2
18
29
TJG20
NOMESCO Finland
Transanal irrigation
15.8
7.2
11
7
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.5
7.2
55
229
K80.0
ICD-10 Finland
Calculus of gallbladder with acute cholecystitis
2.6
7.2
50
196
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.7
7.2
46
172
K75.4
ICD-10 Finland
Autoimmune hepatitis
20.1
7.1
10
5
K60.4
ICD-10 Finland
Rectal fistula
20.1
7.1
10
5
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.1
7.1
80
399
WX320
NOMESCO Finland
Spinalanesthesy
1.5
7.1
264
1874
R19.8
ICD-10 Finland
Other specified symptoms and signs involving the digestive system and abdomen
5.1
7.1
21
42
NG1DA
NOMESCO Finland
X-ray of knees
4.1
7.1
26
65
N02AA05
ATC
oxycodone; systemic
1.7
7.0
139
844
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.7
7.0
161
1018
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
7.0
126
741
SPAT1255
SPAT
Intravenous administration of medicine
2.0
6.9
80
403
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.8
6.9
113
644
K85.8
ICD-10 Finland
Other acute pancreatitis
7.6
6.9
15
20
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
2.2
6.8
65
299
Z01.9
ICD-10 Finland
Special examination, unspecified
2.2
6.8
68
322
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
6.8
345
2609
A04.9
ICD-10 Finland
Bacterial intestinal infection, unspecified
6.1
6.8
17
28
JH1CM
NOMESCO Finland
Perianal extensive MRI with 3 Tesla magnet
40.2
6.8
8
*
5781B
ICD-9 Finland
Gastro-intestinal haemorrhage, Melaena[HAEMORRHAGIA EX ANO]
40.2
6.8
8
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.7
6.8
131
790
J01FF01
ATC
clindamycin; systemic
1.4
6.7
329
2471
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.9
6.7
89
474
JHD96
NOMESCO Finland
Other incision of anal sphincter
22.6
6.7
9
*
L52
ICD-10 Finland
Erythema nodosum
6.5
6.6
16
25
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
3.1
6.6
33
107
JKE22
NOMESCO Finland
Endoscopic extraction of foreign body from bile duct
8.7
6.6
13
15
WX610
NOMESCO Finland
Patient controlled analgesia
4.8
6.5
20
42
B07.9
ICD-10 Finland
Verruca simplex
2.4
6.5
52
220
J01MA01
ATC
ofloxacin; systemic
1.9
6.5
95
524
J01AA02
ATC
doxycycline; systemic
1.3
6.5
1031
9300
M03BC51
ATC
orphenadrine, combinations; systemic
1.4
6.5
368
2838
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.0
6.5
81
422
1380
FHL
Colonoscopy, left side
70.1
6.4
7
*
K83
ICD-10 Finland
Other diseases of biliary tract
70.1
6.4
7
*
K73.0
ICD-10 Finland
Chronic persistent hepatitis, not elsewhere classified
70.1
6.4
7
*
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
6.4
423
3347
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
6.3
283
2088
XX3DW
NOMESCO Finland
Time consuming IT work
1.7
6.3
113
667
JFG70
NOMESCO Finland
Conversion of continent ileostomy to conventional ileostomy
+∞
6.3
6
*
6437
FHL
Rectum resection and sphincter-sparing through-anastomosis
+∞
6.3
6
*
E000003
ATC
NA
2.1
6.2
66
320
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
6.2
1000
9002
A06AC51
ATC
ispaghula, combinations; systemic
2.2
6.2
61
285
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
6.2
390
3053
JX1XE
NOMESCO Finland
Other ultrasound examinaton of alimentary organs
26.8
6.2
8
*
NH3EA
NOMESCO Finland
Feet X-ray examination with load
3.0
6.2
33
112
K02.1
ICD-10 Finland
Caries of dentine
1.3
6.2
818
7155
ZX114
NOMESCO Finland
Intramuscular
3.6
6.2
26
74
EAV
NOMESCO Finland
NA
3.3
6.2
29
90
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.8
6.2
36
129
JKA20
NOMESCO Finland
Cholecystectomy
3.0
6.1
33
113
S02.5
ICD-10 Finland
Fracture of tooth
2.7
6.1
40
153
R03AC02
ATC
salbutamol; inhalant
1.3
6.1
680
5807
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.4
6.1
326
2483
E87.5
ICD-10 Finland
Hyperkalaemia
4.7
6.1
19
41
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
6.1
229
1631
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
3.7
6.1
24
65
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.3
6.0
50
219
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.3
6.0
52
231
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
2.8
6.0
35
125
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
522
644
11.43
307.65
2.4
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
1185
1139
35.00
307.65
2.5
1.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1347
4761
11.30
307.65
12.0
4.5
g/l
36.4
36.3
0.33
1319
4452
(42870588) Differential panel, method unspecified - Blood
1179
4133
7.61
307.65
13.4
5.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
1217
1367
31.75
307.65
7.9
1.3
ug/g
210.8
93.9
16.01
1165
1045
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
340
352
11.93
303.75
1.8
1.5
iu/ml
0.7
0.1
1.23
72
57
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1234
4964
7.02
291.79
4.3
2.1
nmol/l
74.5
74.3
0.06
1200
4544
(3022096) Basophils/100 leukocytes in Blood
1316
5817
7.42
272.95
16.0
5.8
%
0.8
0.7
8.93
1289
5451
(3006504) Eosinophils/100 leukocytes in Blood
1324
6013
7.27
262.00
16.0
5.7
%
2.9
2.8
0.32
1296
5629
(3019069) Monocytes/100 leukocytes in Blood
1326
6061
7.24
259.45
16.3
6.0
%
9.0
8.4
9.85
1302
5711
(3001604) Monocytes [#/volume] in Blood
1362
6390
7.71
258.24
16.1
5.6
e9/l
0.6
0.6
0.43
1313
5581
(3006315) Basophils [#/volume] in Blood
1363
6411
7.71
257.28
16.1
5.6
e9/l
0.0
0.0
2.02
1314
5596
(3030905) Polymorphonuclear cells [#/volume] in Blood
264
242
12.81
254.37
4.5
3.4
e9/l
3.8
4.2
1.77
264
242
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
267
251
12.51
253.04
4.8
3.8
%
57.4
56.5
0.40
267
251
(3013115) Eosinophils [#/volume] in Blood
1373
6644
7.59
246.27
16.3
5.9
e9/l
0.2
0.2
0.44
1321
5886
(3002030) Lymphocytes/100 leukocytes in Blood
1330
6278
6.95
244.83
16.1
5.7
%
28.4
28.8
0.55
1304
5887
(3019198) Lymphocytes [#/volume] in Blood
1367
6615
7.45
244.34
16.2
5.6
e9/l
1.8
2.0
3.17
1323
5887
(3018010) Neutrophils/100 leukocytes in Blood
1317
6184
6.76
243.29
15.1
5.5
%
57.2
56.7
0.87
1293
5822
(3021589) Normoblasts [#/volume] in Blood
1240
5669
5.89
232.19
20.6
8.7
e9/l
0.0
0.0
1.12
1176
4666
(3025159) Blasts/100 leukocytes in Blood
458
915
6.56
230.88
6.3
4.5
%
0.0
0.5
0.66
104
229
(3002179) Metamyelocytes/100 leukocytes in Blood
459
930
6.47
227.84
6.0
4.1
%
0.5
0.6
0.40
107
214
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
827
2794
4.96
226.21
4.4
1.9
mg/l
2.9
2.9
0.04
766
2396
(3021440) Promyelocytes/100 leukocytes in Blood
461
970
6.22
219.34
6.4
4.4
%
0.1
0.1
0.43
109
264
(3017181) Myelocytes/100 leukocytes in Blood
470
1012
6.11
218.10
6.3
4.3
%
0.7
0.9
0.79
118
284
(3013650) Neutrophils [#/volume] in Blood by Automated count
1399
7364
7.17
213.05
18.1
8.9
e9/l
3.9
4.1
3.39
1355
6462
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
169
124
15.08
185.02
1.2
1.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1547
9600
12.01
177.24
21.5
6.8
u/l
77.5
76.3
0.51
1524
9056
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
212
247
9.71
170.85
3.6
7.2
iu/ml
517.8
386.4
0.20
27
39
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
395
1038
4.70
140.57
3.6
2.2
g/l
0.2
0.2
0.51
381
966
(3007566) Smooth muscle Ab [Titer] in Serum
225
356
7.17
139.24
2.1
1.2
titre
62.6
100.3
1.49
19
37
(40761536) Microorganisms panel - Urine sediment
388
1073
4.43
128.43
4.3
3.6
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
216
364
6.68
125.50
2.0
1.2
titre
—
1450.9
—
0
11
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
894
4425
3.25
119.26
6.0
3.3
u/l
30.4
31.7
0.77
791
4230
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
452
1467
3.87
119.08
3.1
2.5
%
22.1
24.4
2.48
428
1276
(3013707) Erythrocyte sedimentation rate by Westergren method
1416
9396
4.74
115.17
8.1
3.7
mm/h
12.5
10.2
8.27
1362
8796
(40760892) CBC W Ordered Manual Differential panel - Blood
702
3082
3.24
113.79
11.3
4.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
706
3145
3.19
111.06
13.0
6.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
115
104
11.82
110.12
2.5
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
290
758
4.43
101.85
2.2
1.8
g/l
1.3
1.4
0.63
277
703
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
102
88
12.29
100.58
2.8
1.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
447
1602
3.46
99.41
3.1
2.4
g/l
2.4
2.4
0.36
431
1492
(3022948) Iron [Moles/volume] in Serum or Plasma
469
1756
3.34
96.91
3.1
2.4
umol/l
13.0
14.2
2.51
451
1636
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
92
0
+∞
96.84
2.4
0.0
mg/l
20.7
—
—
86
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
92
0
+∞
96.84
2.4
0.0
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
914
5001
2.87
94.79
2.6
2.0
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
101
96
11.15
93.40
1.6
1.1
titre
302.0
187.1
0.53
45
14
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
101
96
11.15
93.40
1.6
1.1
titre
414.3
—
—
7
0
(3005719) IgG [Mass/volume] in Serum or Plasma
324
979
3.88
92.80
3.0
2.6
g/l
11.9
10.4
9.50
304
897
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1037
6292
2.77
84.22
10.3
6.1
umol/l
11.0
11.3
0.36
999
5973
(3025941) Bacteria identified in Stool by Culture
261
724
4.10
83.86
1.7
1.2
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
460
1838
3.09
83.68
1.5
1.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
177
368
5.27
81.51
6.4
3.4
u/ml
45.8
3926.0
0.81
160
314
(3024980) IgG subclass 4 [Mass/volume] in Serum
131
208
6.76
79.87
2.8
1.7
g/l
0.9
0.9
0.13
106
159
(3001122) Ferritin [Mass/volume] in Serum or Plasma
976
5856
2.65
79.19
4.6
2.7
ug/l
100.5
115.9
0.67
920
5502
(3018418) pH of Serum or Plasma
655
3243
2.70
78.86
5.3
4.0
ph
7.4
7.4
0.13
199
642
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
337
1155
3.41
78.84
3.7
2.4
u/l
37.9
81.0
0.53
310
993
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
138
246
6.03
74.95
1.5
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
803
4474
2.56
74.72
10.4
7.5
inr
1.1
1.2
4.77
415
1386
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
336
1202
3.26
72.88
3.8
3.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
536
2562
2.62
67.35
1.6
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
421
1790
2.82
66.60
2.4
1.6
nmol/l
1196.5
1187.0
0.06
234
1391
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
500
2333
2.65
65.76
3.0
1.6
pmol/l
9734941.7
40251052.6
1.27
452
1995
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
691
3801
2.41
63.35
4.3
2.5
u/l
60.3
56.9
0.87
671
3542
(3037522) Nuclear Ab [Titer] in Serum
417
1830
2.72
61.49
1.8
1.3
titre
412.9
482.7
0.40
121
359
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
348
1406
2.87
60.00
5.6
2.7
umol/l
6.6
7.9
0.88
310
1225
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
820
4992
2.29
57.87
6.8
5.9
mmol/l
1.2
1.2
2.71
767
4560
(3052851) Hemolysis interference index of Serum or Plasma
140
321
4.68
57.01
3.1
3.3
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
578
3098
2.34
54.46
7.9
3.7
%
94.5
92.9
0.90
558
3027
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
79
111
7.43
53.68
1.1
1.2
u/l
52.2
57.1
0.32
66
73
(40768441) Liver Pathology biopsy report
68
86
8.21
50.53
1.8
1.5
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
863
5577
2.16
50.01
7.3
6.5
mmol/l
1.2
1.2
1.22
678
4737
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1529
12703
4.06
49.66
26.8
10.4
ml/min/173m2
89.0
87.7
1.62
1441
10413
(3002385) Erythrocyte distribution width [Ratio]
1438
11531
3.02
49.59
33.5
14.2
%
13.8
13.5
8.45
1429
11289
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
152
412
3.96
49.58
2.3
1.6
titre
257.5
308.3
—
8
12
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
266
1023
2.91
49.57
6.3
4.3
ug/l
13.3
27.2
0.54
201
832
(3023368) Bacteria identified in Blood by Culture
544
2938
2.28
49.45
6.3
4.2
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
75
109
7.16
49.43
1.9
1.5
umol/l
10.5
11.6
0.87
75
101
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1577
13464
5.60
47.51
31.6
11.5
mg/l
15.1
22.3
27.79
1440
10430
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
90
167
5.64
46.63
1.2
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
116
273
4.50
45.59
1.2
1.2
u/ml
345.0
248.5
1.54
70
171
(36304419) Bacteria [Presence] in Urine
565
3185
2.18
45.49
3.4
2.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
568
3211
2.18
45.38
3.5
2.9
e6/l
0.6
0.4
0.67
486
2387
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
237
904
2.90
44.59
4.5
3.7
mmol/l
1.2
1.2
2.15
212
782
(3029937) Albumin [Presence] in Urine by Test strip
577
3304
2.15
44.42
4.1
3.4
estimate
0.0
0.0
0.40
388
1165
(3026782) Osmolality of Urine
439
2253
2.30
44.33
2.9
2.6
mosm/kgh2o
533.2
554.9
1.13
400
1940
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
97
203
5.02
43.93
6.5
3.9
u/ml
72.9
290.4
0.97
86
189
(3000850) Epithelial cells [#/volume] in Urine
459
2410
2.26
43.81
2.8
2.5
e6/l
6.8
6.1
0.35
420
2126
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
115
289
4.20
41.47
1.1
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
597
3546
2.08
41.04
3.5
3.0
e6/l
75.1
81.7
0.05
514
2704
(3009445) Proteinase 3 Ab [Units/volume] in Serum
159
512
3.33
39.89
2.2
1.4
u/ml
8.1
10.0
—
23
9
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
44
43
10.49
39.67
3.7
3.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
337
1656
2.30
36.97
1.3
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
273
1225
2.47
36.76
2.4
2.1
nmol/l
317.7
372.0
5.05
247
1144
(3006922) Hepatitis E virus Ab [Presence] in Serum
60
95
6.52
36.46
1.1
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
53
74
7.37
36.15
1.6
1.5
u/l
6.5
6.9
0.05
38
29
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
150
499
3.21
35.60
1.2
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
57
91
6.45
34.36
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
57
91
6.45
34.36
1.1
1.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1138
8777
1.97
34.05
4.9
3.8
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
45
57
8.09
33.33
23.5
27.4
ug/l
136.4
122.9
0.38
40
43
(3018095) Leukocytes [#/volume] in Urine
653
4245
1.90
32.82
3.9
3.4
e6/l
46.6
89.0
1.15
534
2923
(40767503) Oxygen content in Capillary blood by calculation
90
227
4.14
32.25
2.6
2.5
%
16.7
16.5
0.12
46
118
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
673
4449
1.87
31.85
2.3
1.8
pmol/l
93.6
96.4
0.92
424
2421
(3007164) IgA [Mass/volume] in Serum or Plasma
458
2679
1.99
31.29
2.0
1.4
g/l
2.8
2.3
5.70
334
1728
(46235355) HIV 1 and 2 tests - Meaningful Use set
525
3222
1.93
31.10
1.7
1.9
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
572
3618
1.89
30.85
3.8
2.8
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
870
6268
1.83
30.83
4.6
4.3
estimate
0.0
0.0
0.50
398
1205
(3042936) Bacteria identified in Isolate by Culture
327
1701
2.15
30.66
2.6
2.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
876
6331
1.82
30.66
3.7
3.2
estimate
0.0
0.0
0.80
389
1141
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
88
228
4.02
30.40
1.8
1.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
867
6264
1.82
30.20
3.7
3.1
estimate
0.0
0.0
0.80
391
1166
(3012501) Base excess in Blood by calculation
92
248
3.87
30.08
3.4
4.3
mmol/l
2.0
2.3
0.30
57
164
(1616796) Gas panel - Central venous blood
90
239
3.93
30.05
2.9
3.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
958
7160
1.81
29.54
6.2
4.6
mmol/l
6.5
6.6
0.52
911
6644
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
113
358
3.32
28.97
4.1
2.9
mg/l
1.4
1.5
0.34
105
332
(3010421) pH of Blood
100
296
3.53
28.51
3.4
4.1
ph
7.4
7.4
0.48
89
244
(3012095) Magnesium [Moles/volume] in Serum or Plasma
344
1888
2.04
27.70
5.5
3.5
mmol/l
0.8
0.8
5.95
324
1787
(3021960) Folate [Moles/volume] in Serum or Plasma
414
2441
1.93
27.06
1.7
1.5
nmol/l
20.3
20.6
0.14
363
2134
(3048929) Epstein Barr virus Ab [Presence] in Serum
132
487
2.86
26.01
1.2
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
119
415
3.01
25.94
1.8
1.8
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
212
991
2.31
25.54
9.6
8.3
mmol/l
8.6
8.8
0.17
205
954
(3003458) Phosphate [Moles/volume] in Serum or Plasma
279
1485
2.06
24.16
7.4
6.1
mmol/l
1.0
1.0
1.26
264
1394
(3021879) Hepatitis B virus core Ab [Presence] in Serum
240
1222
2.13
23.33
1.3
1.5
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
73
208
3.63
22.04
2.3
2.8
u/ml
180.0
1472.4
—
5
14
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1578
14490
3.43
21.69
26.3
9.0
u/l
27.3
28.1
1.35
1559
14069
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
680
4908
1.66
21.13
3.9
3.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
316
1837
1.89
20.97
2.8
2.6
e6/l
2.0
2.4
0.43
190
974
(3004809) Band form neutrophils/100 leukocytes in Blood
63
171
3.79
20.41
2.7
3.4
%
0.9
1.8
1.68
52
151
(4035726)
204
1025
2.13
20.40
1.5
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
87
293
3.08
20.14
1.3
1.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
83
272
3.16
20.12
1.4
1.5
u/ml
106.9
120.8
0.33
12
56
(3002256) Pathology report gross observation
277
1576
1.91
19.52
1.3
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
320
1928
1.82
18.76
2.7
2.5
e6/l
0.7
1.0
2.13
196
1055
(3014765) Yersinia sp identified in Stool by Organism specific culture
95
353
2.80
18.45
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
95
357
2.76
18.06
1.3
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
20
20
10.11
17.61
1.6
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
93
353
2.73
17.35
1.3
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
255
1466
1.88
17.27
2.0
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
178
909
2.08
16.96
3.2
2.9
e9/l
4.1
4.1
0.20
144
752
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
15
11
13.75
15.93
1.1
1.0
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
73
256
2.94
15.78
2.2
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
83
314
2.73
15.59
1.1
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
41
101
4.14
15.21
1.1
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
69
246
2.88
14.49
1.1
1.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
46
128
3.67
14.43
2.1
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
200
1124
1.89
14.41
3.8
2.8
%
1.9
1.8
0.72
182
1013
(3019550) Sodium [Moles/volume] in Serum or Plasma
1475
13502
1.93
14.26
23.7
12.8
mmol/l
139.3
139.7
9.87
1437
13157
(3031040) Bacteria [#/volume] in Urine by Automated count
981
8154
1.51
14.13
4.8
3.8
e6/l
52.2
1481.1
1.25
13
106
(3028192) IgG subclass 2 [Mass/volume] in Serum
46
131
3.58
13.96
1.2
1.3
g/l
3.2
3.0
0.19
24
91
(3024139) IgG subclass 3 [Mass/volume] in Serum
46
131
3.58
13.96
1.2
1.3
g/l
0.4
0.3
0.70
24
89
(3027135) IgG subclass 1 [Mass/volume] in Serum
46
131
3.58
13.96
1.2
1.3
g/l
9.3
6.4
2.04
24
91
(40761511) CBC panel - Blood by Automated count
1538
14307
2.23
13.94
22.8
10.9
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
46
132
3.56
13.81
2.2
1.4
—
—
—
0
0
(4062490)
46
132
3.56
13.81
1.2
1.3
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
46
132
3.56
13.81
2.2
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
58
193
3.08
13.76
1.1
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
28
55
5.16
13.65
2.2
5.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1476
13552
1.90
13.58
24.0
12.9
mmol/l
3.9
4.0
7.48
1439
13182
(3044640) Blood type and Crossmatch panel - Blood
530
3907
1.53
13.49
3.5
2.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
71
268
2.72
13.42
5.0
3.4
umol/l
31.4
35.4
1.21
60
231
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
78
310
2.59
13.32
3.8
3.2
u/ml
0.3
0.3
0.62
49
164
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
29
62
4.74
12.85
1.1
1.2
u/l
60.9
27.6
0.32
23
47
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
206
1213
1.80
12.74
3.3
4.3
u/l
230.4
246.6
0.67
200
1160
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
22
37
6.01
12.60
1.3
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
59
209
2.89
12.57
1.1
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
56
194
2.95
12.41
2.9
2.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
246
1537
1.71
12.34
1.7
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
43
130
3.37
11.95
2.2
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
746
6000
1.45
11.84
5.5
3.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
102
484
2.18
11.73
1.3
1.2
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
94
432
2.25
11.69
1.9
2.0
g/l
1.4
1.5
0.38
83
379
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
43
132
3.32
11.67
2.2
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
43
132
3.32
11.67
2.2
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
208
1261
1.74
11.60
16.5
17.7
inr
1.3
1.2
0.25
21
187
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
570
4413
1.45
10.83
3.4
3.1
ng/l
51.4
42.9
0.16
361
2681
(3006184) Hemoglobin [Mass/volume] in Capillary blood
62
245
2.59
10.76
2.6
2.3
g/l
131.2
131.5
0.03
52
181
(3000991) Gas panel - Venous blood
155
883
1.83
10.65
10.0
9.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
61
241
2.59
10.59
1.1
1.1
—
—
—
0
0
(3044889) 12 lead EKG panel
1033
8923
1.43
10.50
3.8
3.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
78
350
2.29
10.29
2.0
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
144
811
1.85
10.26
4.5
2.8
e9/l
77.1
72.6
0.56
106
613
(3015377) Calcium [Moles/volume] in Serum or Plasma
503
3835
1.45
10.25
3.6
3.3
mmol/l
2.3
2.4
0.61
461
3447
(3009542) Hematocrit [Volume Fraction] of Blood
1412
13009
1.62
10.14
26.6
12.2
%
40.3
40.8
1.68
1083
10288
(3002032) Base excess in Venous blood by calculation
161
942
1.79
10.13
6.2
3.6
mmol/l
1.2
1.9
1.62
127
759
(3024471) HLA-A [Type]
24
54
4.50
10.03
1.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
35
104
3.42
10.03
4.9
3.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
65
274
2.43
9.88
3.1
2.2
g/l
38.1
38.2
0.02
60
243
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
121
656
1.91
9.70
1.6
1.5
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
38
122
3.16
9.64
2.5
1.4
g/l
0.8
1.0
3.28
38
122
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
415
3081
1.46
9.63
1.4
1.2
u/ml
1.0
1.9
2.54
96
875
(3017354) Segmented neutrophils/100 leukocytes in Blood
33
97
3.45
9.62
2.5
3.4
%
57.2
51.5
0.74
22
74
(3024932) HLA-DR beta [Type]
23
53
4.39
9.34
1.0
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
73
333
2.25
9.29
2.9
2.2
g/l
3.0
3.1
0.77
62
264
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
68
305
2.28
9.01
3.0
2.3
g/l
0.7
0.8
0.13
63
277
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
70
320
2.24
8.87
2.9
2.2
g/l
12.2
10.5
2.04
62
282
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
254
1738
1.55
8.66
2.1
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
74
354
2.14
8.40
2.9
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
74
354
2.14
8.40
2.9
2.2
g/l
6.9
7.3
1.17
61
275
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
74
354
2.14
8.40
2.9
2.2
g/l
3.8
3.8
0.09
61
258
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
394
2965
1.43
8.35
3.2
2.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
27
77
3.55
8.26
5.6
3.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
409
3114
1.42
8.09
3.1
2.6
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
19
43
4.46
7.90
1.4
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
19
44
4.36
7.69
1.4
1.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
37
134
2.80
7.67
3.0
2.4
pg
32.9
32.5
0.15
37
134
(3045414) Leukocytes [Presence] in Urine
101
561
1.85
7.55
2.0
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
115
665
1.78
7.55
2.3
2.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
152
963
1.64
7.16
3.3
2.4
ml/min/173m2
67.0
72.8
0.93
71
367
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
382
2936
1.39
7.03
2.0
1.7
mg/l
1.6
1.0
1.87
289
2193
(3000570) Elastase.pancreatic [Mass/mass] in Stool
68
339
2.05
6.98
1.5
1.4
ug/g
284.7
304.2
0.29
45
191
(3008757) Leukocyte morphology finding [Identifier] in Blood
32
113
2.87
6.97
3.4
3.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
103
594
1.78
6.84
1.8
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
103
596
1.78
6.77
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
66
331
2.04
6.68
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
17
41
4.18
6.55
1.5
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
17
41
4.18
6.55
1.5
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
20
55
3.67
6.48
1.1
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
132
829
1.64
6.45
2.3
2.6
g/l
68.2
67.2
0.75
126
772
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1083
9769
1.32
6.42
5.6
3.0
u/l
56.6
46.0
3.41
1022
9283
(3007461) Platelets [#/volume] in Blood
1588
15367
2.09
6.41
41.8
17.1
e9/l
272.8
253.4
20.74
1573
15033
(3009871) Measles virus Ab [Titer] in Serum
19
51
3.76
6.37
1.8
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
46
207
2.26
6.14
4.4
3.2
—
—
—
0
0
(3024731) MCV [Entitic volume]
1588
15383
2.06
6.13
41.7
17.0
fl
91.8
90.4
24.03
1577
15205
(3035941) MCH [Entitic mass]
1588
15384
2.06
6.11
41.6
17.0
pg
30.4
30.2
4.36
1577
15204
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
16
39
4.13
6.09
1.1
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
40
170
2.39
6.08
1.6
1.3
mmol/l
63.8
63.9
0.00
19
148
(3026361) Erythrocytes [#/volume] in Blood
1588
15386
2.05
6.08
41.8
17.0
e12/l
4.5
4.6
20.74
1570
15024
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
19
53
3.62
6.04
1.1
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1588
15392
2.04
5.97
41.9
17.1
e9/l
6.8
6.7
0.36
1572
15024
(3000963) Hemoglobin [Mass/volume] in Blood
1588
15393
2.04
5.95
42.2
17.1
g/l
135.1
138.2
15.17
1577
15213
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
43
191
2.29
5.93
2.2
2.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
259
1913
1.42
5.93
3.8
2.9
mmol/l
2.5
2.4
1.62
233
1699
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
21
64
3.31
5.87
1.1
1.0
miu/ml
1493.8
1699.9
0.35
21
64
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
25
85
2.97
5.85
1.1
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
25
85
2.97
5.85
1.1
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
41
180
2.31
5.81
1.1
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
18
50
3.63
5.76
1.4
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
118
743
1.63
5.73
1.4
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
114
713
1.64
5.68
3.1
3.2
kpa
5.0
5.2
1.54
109
670
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
48
229
2.13
5.59
1.5
1.6
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
14
33
4.27
5.56
1.4
2.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
307
2360
1.37
5.53
1.3
1.3
iu/ml
21.8
28.6
0.69
89
724
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
109
679
1.65
5.52
3.1
3.3
mmol/l
1.3
1.6
0.42
78
504
(3000330) Specific gravity of Urine by Test strip
87
510
1.75
5.51
2.6
3.0
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
170
1178
1.49
5.43
2.0
1.7
—
—
—
0
0
(3009343) pH of Capillary blood
112
706
1.63
5.42
3.1
3.2
ph
7.4
7.4
0.25
37
92
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
293
2247
1.37
5.35
1.3
1.3
u/ml
7.2
11.1
0.67
107
939
(3026493) Urate [Moles/volume] in Serum or Plasma
410
3309
1.32
5.32
2.9
2.4
umol/l
1820.7
4668.7
1.57
369
2953
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
25
90
2.81
5.31
1.9
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
32
132
2.45
5.22
1.9
2.0
—
—
—
0
0
(3004451) EKG impression Narrative
18
54
3.36
5.17
1.2
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
42
198
2.15
5.06
1.7
1.9
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
35
153
2.32
5.05
1.5
1.3
—
—
—
0
0
(3013512) EKG study
397
3211
1.31
5.04
3.1
3.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1101
10101
1.27
4.94
3.4
3.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
169
1193
1.46
4.93
2.0
1.8
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
43
208
2.10
4.87
2.1
2.2
umol/l
15.6
5.4
1.38
29
151
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
21
73
2.90
4.77
1.3
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
116
762
1.56
4.76
2.7
2.3
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
29
120
2.44
4.73
2.3
2.4
e9/l
1.3
1.2
0.10
17
69
(21494815) CD4 cells/100 lymphocytes in Specimen
28
116
2.44
4.56
2.2
2.2
%
54.8
43.7
—
6
18
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
35
161
2.20
4.51
1.8
1.8
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
52
285
1.85
4.18
3.4
3.5
mg/l
42.3
32.5
0.77
37
224
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
68
405
1.71
4.15
1.8
2.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
52
287
1.84
4.10
1.8
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
50
875
0.56
4.10
1.2
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
92
1383
0.65
4.07
8.1
5.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
361
2960
1.28
4.05
1.7
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
143
1966
0.70
3.99
1.2
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
32
150
2.16
3.97
1.6
1.4
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
16
53
3.04
3.97
1.6
1.3
%
7.7
4.3
—
8
13
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
114
781
1.49
3.90
4.6
4.0
ng/l
110.3
83.9
1.16
106
706
(3034860) Kappa light chains.free [Mass/volume] in Serum
51
285
1.81
3.88
3.5
3.5
mg/l
51.6
75.2
0.48
36
225
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
34
656
0.51
3.86
2.2
1.8
mg/l
2.8
3.8
0.75
21
456
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
6
5
12.04
3.76
1.0
1.0
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
18
66
2.75
3.76
1.1
1.8
iu/ml
—
772331.3
—
0
8
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
40
209
1.94
3.74
1.6
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
40
209
1.94
3.74
1.6
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
30
142
2.13
3.66
3.9
2.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
41
218
1.90
3.65
2.6
3.7
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
22
91
2.44
3.64
2.0
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
76
1155
0.64
3.56
1.2
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
9
17
5.32
3.51
2.6
1.9
—
—
—
0
0
(3036489) Thrombin time
77
498
1.57
3.45
2.5
2.1
s
21.8
21.1
0.94
71
434
(3012565) Volume of 24 hour Urine
18
70
2.59
3.38
1.8
3.1
ml
1801.1
2016.8
0.41
18
63
(40761539) Cells [Type] in Urine sediment by Light microscopy
10
27
3.72
3.35
1.0
1.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
89
600
1.51
3.32
1.8
2.1
u/l
37.5
39.6
0.46
75
549
(3011325) HIV 1+2 Ab [Presence] in Serum
6
7
8.60
3.26
1.0
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
263
3211
0.78
3.23
3.5
3.6
%
20.0
21.0
0.43
113
1319
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
20
84
2.40
3.23
1.8
2.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
36
192
1.89
3.21
1.4
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
30
150
2.02
3.21
1.1
1.4
nmol/l
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
43
729
0.58
3.19
1.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
11
33
3.35
3.19
1.1
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
13
44
2.97
3.14
1.0
1.4
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
50
2.82
3.09
1.4
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
50
2.82
3.09
1.4
2.0
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
63
401
1.59
3.05
1.4
1.6
g/l
1.2
1.2
0.11
55
378
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
398
3400
1.23
3.04
1.8
1.6
mmol/l
1.5
1.4
1.06
316
2918
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
17
68
2.52
3.04
1.2
1.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
21
93
2.27
3.03
2.0
2.1
%
11.8
14.2
—
8
43
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
26
500
0.51
2.99
1.3
1.5
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
217
2687
0.78
2.98
3.6
3.4
kg/l
1.0
1.0
0.48
21
352
(3020393) Adenovirus Ag [Presence] in Stool
6
9
6.69
2.87
1.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
61
392
1.58
2.86
1.3
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
47
283
1.68
2.85
1.8
1.7
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
26
130
2.02
2.81
1.9
1.5
%
48.7
57.9
0.50
18
87
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
36
3.07
2.81
1.4
2.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
219
1765
1.28
2.80
3.2
2.2
s
31.1
29.6
2.07
211
1708
(3011397) Hemoglobin [Presence] in Urine by Test strip
326
2754
1.23
2.76
3.2
3.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
108
1456
0.72
2.71
3.7
4.0
%
32.2
31.1
0.42
85
1046
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
11
37
2.99
2.69
1.1
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
113
834
1.38
2.66
2.9
3.3
pmol/l
4.4
4.6
0.88
99
751
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
36
602
0.59
2.59
2.3
1.9
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
25
128
1.97
2.56
1.2
1.4
—
—
—
0
0
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
12
44
2.74
2.55
1.3
1.3
nmol/l
274.0
144.8
—
6
35
(3021788) Differential panel - Synovial fluid
35
201
1.76
2.53
1.9
1.5
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
13
50
2.61
2.53
1.5
1.9
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
425
3717
1.19
2.50
3.5
3.3
mmol/l
8.4
8.2
0.40
354
3189
(3024928) Oxygen saturation in Venous blood
39
232
1.70
2.50
4.2
2.6
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
59
390
1.53
2.48
1.4
1.6
g/l
0.2
0.2
0.49
51
368
(3029075) Extractable nuclear Ab panel - Serum
11
39
2.83
2.47
1.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
37
218
1.71
2.46
1.1
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
12
45
2.68
2.45
1.5
2.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1251
13017
0.84
2.44
3.8
3.6
mmol/l
1.4
1.3
1.95
1152
12212
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
250
2080
1.24
2.44
1.9
1.9
%
1.4
1.4
0.03
208
1875
(21494434) Karyotype in Bone marrow
20
96
2.10
2.43
1.2
1.3
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
56
368
1.54
2.43
2.0
2.3
mg/l
10.2
10.7
0.17
49
342
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
158
0.31
2.42
1.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
21
103
2.05
2.42
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
21
103
2.05
2.42
1.3
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1081
10211
1.17
2.42
3.9
3.8
pmol/l
14.7
14.6
0.65
989
9462
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
28
153
1.84
2.39
1.1
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
30
168
1.80
2.37
1.2
1.4
nmol/l
0.5
0.6
0.46
30
160
(40768795) Lymph node Pathology biopsy report
23
118
1.96
2.36
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
78
553
1.43
2.34
1.3
1.3
miu/ml
279.0
212.4
0.68
36
272
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
27
147
1.85
2.33
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
21
105
2.01
2.31
1.3
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
21
105
2.01
2.31
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
21
105
2.01
2.31
1.3
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
38
231
1.66
2.28
1.6
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
374
3260
1.19
2.27
3.7
3.3
mg/l
367.4
266.8
0.17
253
2125
(3009214) Lutropin [Units/volume] in Serum or Plasma
74
523
1.43
2.27
1.6
1.4
u/l
8.4
8.8
0.09
62
433
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
13
4.63
2.27
1.7
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
137
1071
1.30
2.24
1.2
1.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
152
1206
1.29
2.23
7.5
8.4
mmol/l
0.1
1.1
1.61
117
946
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
9
29
3.11
2.22
1.1
1.1
%
90.7
96.7
—
9
29
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
9
29
3.11
2.22
1.1
1.1
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
14
60
2.34
2.22
1.1
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
108
818
1.34
2.21
1.5
1.3
iu/l
22.8
25.1
0.36
97
695
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
152
1209
1.28
2.19
7.5
8.4
kpa
4.9
5.1
3.04
144
1159
(3050129) First trimester maternal screen panel - Serum or Plasma
36
573
0.62
2.17
1.5
1.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
8
199
0.40
2.16
2.3
2.0
—
1088.0
—
0
10
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
16
74
2.17
2.15
1.8
1.7
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
52
347
1.51
2.14
2.2
3.0
—
—
—
0
0
(4034850)
23
409
0.56
2.12
7.4
8.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1305
13486
0.84
2.09
4.1
3.9
mmol/l
1.5
1.4
1.17
1215
12687
(3027801) Oxygen [Partial pressure] in Arterial blood
151
1210
1.27
2.06
7.5
8.4
kpa
13.2
12.6
0.81
143
1163
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
20
103
1.95
2.05
1.3
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
24
132
1.83
2.04
1.0
1.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
7
178
0.39
2.02
1.1
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
34
209
1.64
1.98
1.5
1.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
14
64
2.20
1.94
1.9
1.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
27
157
1.73
1.93
1.5
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
135
1677
0.79
1.93
1.3
1.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
15
71
2.12
1.92
1.1
1.2
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
172
0.40
1.91
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
18
92
1.97
1.90
1.2
1.1
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
23
128
1.81
1.90
1.1
1.6
mosm/kgh2o
278.3
281.2
0.13
17
102
(3013293) Extractable nuclear Ab [Presence] in Serum
7
22
3.19
1.88
1.1
2.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
9
34
2.66
1.86
1.0
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
20
107
1.88
1.86
2.1
1.4
%
39.3
35.7
0.16
14
71
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
254
2179
1.20
1.85
3.4
3.3
ng/l
233.6
529.8
1.75
174
1498
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
13
59
2.21
1.84
1.7
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
13
59
2.21
1.84
1.7
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
13
59
2.21
1.84
1.7
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
13
59
2.21
1.84
1.7
1.6
—
—
—
0
0
(4211845)
12
53
2.27
1.81
1.7
2.7
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
24
138
1.75
1.80
2.9
2.9
nmol/l
1.0
0.9
0.29
18
102
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
27
161
1.69
1.78
1.9
1.8
—
—
—
0
0
(3019977) pH of Arterial blood
11
47
2.35
1.78
1.5
3.6
ph
7.4
7.4
—
5
12
(3000492) Spirometry study
175
1455
1.23
1.76
1.6
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
212
1799
1.20
1.74
1.5
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
150
1810
0.81
1.67
1.7
1.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
12
55
2.19
1.67
1.7
1.2
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
13
62
2.11
1.65
1.1
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
42
286
1.48
1.63
1.2
1.2
u/ml
79.3
41.1
—
5
24
(3025130) Human papilloma virus identified in Specimen
33
213
1.56
1.63
2.0
1.8
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
66
490
1.36
1.60
1.7
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
43
2.33
1.60
7.5
4.7
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
10
43
2.33
1.60
1.3
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
13
63
2.07
1.60
2.6
3.6
u/ml
604.6
1128.9
0.74
13
63
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
36
528
0.67
1.55
1.7
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
13
64
2.04
1.54
1.9
1.8
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
44
2.28
1.53
2.9
2.7
—
—
—
0
0
(4268621)
26
161
1.62
1.53
3.0
2.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
28
177
1.59
1.52
1.5
1.7
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
27
2.60
1.51
2.3
3.5
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
6
144
0.41
1.51
5.0
13.9
nmol/l
753.3
799.9
—
6
138
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1337
13715
0.86
1.51
4.4
4.3
mmol/l
2.7
2.9
5.92
1234
12877
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
22
131
1.69
1.49
1.1
1.7
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
205
2369
0.85
1.46
2.8
2.7
ug/l
0.6
0.7
0.76
130
1384
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
33
484
0.68
1.44
1.6
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
33
483
0.68
1.43
1.6
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
43
304
1.43
1.41
1.0
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
42
296
1.43
1.40
1.2
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
379
3433
1.14
1.37
4.8
4.1
mg/mmol
6.1
9.5
1.52
248
2234
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
37
523
0.70
1.34
2.2
2.3
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
34
485
0.69
1.31
1.6
1.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
24
2.51
1.30
1.0
1.3
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
307
2753
1.14
1.30
2.7
3.0
ng/l
1192.4
1074.4
0.22
254
2283
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
34
484
0.70
1.29
1.6
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1254
12885
0.89
1.29
4.0
4.0
mmol/l
5.8
5.8
0.17
1137
11977
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
18
2.78
1.28
3.2
1.4
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
18
2.78
1.28
2.4
2.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
8
35
2.29
1.27
2.8
2.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
56
424
1.33
1.25
1.3
1.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
46
338
1.37
1.24
1.2
1.3
u/ml
17.8
8.0
—
8
56
(3002523) Influenza virus A Ag [Presence] in Specimen
42
304
1.39
1.24
1.0
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
13
70
1.86
1.24
1.2
1.3
nmol/l
121.5
144.0
1.06
13
70
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
45
330
1.37
1.23
1.2
1.3
u/ml
21.1
2.5
—
6
36
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
213
1.46
1.21
1.8
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
384
3511
1.12
1.19
2.2
2.1
u/l
222.2
247.5
0.18
360
3327
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
16
94
1.71
1.17
1.9
2.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
11
57
1.94
1.17
1.5
1.7
—
10.8
—
0
5
(3047007) Chlamydophila sp Ab [Presence] in Serum
34
240
1.43
1.16
1.1
1.2
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
26
174
1.50
1.15
1.1
1.1
%
96.6
97.1
0.03
26
164
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
5
20
2.50
1.15
2.8
1.3
ug/l
0.3
0.4
—
5
11
(3002619) Bacteria identified in Specimen by Culture
5
20
2.50
1.15
1.4
1.2
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
20
2.50
1.15
1.4
1.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
112
0.44
1.13
3.2
2.5
—
—
—
0
0
(3017704) Immunofixation for Urine
11
58
1.90
1.12
1.0
1.7
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
70
873
0.79
1.12
2.1
2.2
ug/l
9.5
8.0
0.27
64
789
(3035320) C reactive protein [Mass/volume] in Body fluid
16
96
1.67
1.10
1.6
2.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
7
32
2.19
1.08
1.1
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
72
578
1.26
1.07
10.8
11.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
33
236
1.41
1.07
1.0
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
17
105
1.63
1.06
4.2
3.9
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
17
105
1.63
1.06
2.9
2.3
e6/l
799.1
733.2
—
10
43
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1327
13549
0.89
1.05
4.3
4.0
mmol/l
4.7
4.7
2.58
1238
12812
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
27
187
1.45
1.04
1.8
1.5
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
13
215
0.60
1.03
1.5
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
10
53
1.89
1.01
1.1
4.0
umol/l
56.0
115.1
—
5
28
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
35
2.00
1.00
1.1
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
16
99
1.62
1.00
1.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
16
99
1.62
1.00
1.6
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
16
99
1.62
1.00
1.6
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
30
412
0.72
0.98
1.6
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
30
215
1.40
0.98
1.1
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
37
275
1.35
0.97
1.8
1.4
nmol/l
0.5
0.4
0.45
28
218
(3020891) Body temperature
51
398
1.29
0.97
4.7
5.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
146
1271
1.16
0.97
2.3
2.2
nmol/l
12.1
13.4
1.32
134
1155
(3017569) Oxygen content in Arterial blood
9
50
1.80
0.96
1.2
3.3
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
15
235
0.63
0.96
1.9
2.3
—
4.2
—
0
6
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
82
679
1.22
0.95
3.0
2.2
u/l
13127.7
4589.9
0.50
27
266
(3051387) C reactive protein [Mass/volume] in Capillary blood
17
258
0.66
0.95
5.7
3.5
mg/l
22.1
27.9
—
9
158
(3049717) Cytology report of Urine Cyto stain
50
391
1.29
0.94
2.2
2.4
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
17
109
1.57
0.93
1.6
1.8
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
16
245
0.65
0.93
4.0
3.9
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
28
2.15
0.91
1.7
1.6
—
—
—
0
0
(4306422)
33
244
1.36
0.91
1.1
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
25
177
1.42
0.88
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
32
425
0.75
0.87
1.6
1.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
31
1.94
0.84
1.8
2.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
31
1.94
0.84
1.8
2.3
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
15
96
1.57
0.84
1.2
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
30
399
0.75
0.83
1.6
1.4
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
49
391
1.26
0.81
2.5
2.5
ug/l
245.7
402.3
0.86
43
368
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
14
89
1.58
0.81
1.7
2.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
47
1.71
0.80
1.4
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
47
1.71
0.80
1.4
1.7
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
47
374
1.26
0.80
1.3
1.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
18
122
1.48
0.80
2.6
2.2
mg/l
41.5
24.2
—
8
35
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1249
12226
1.09
0.79
4.5
4.4
mu/l
1.7
2.2
1.72
1161
11401
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
48
1.67
0.78
1.5
1.7
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
0
27
0.00
0.77
0.0
3.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
34
1.77
0.76
9.0
15.7
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
31
235
1.33
0.76
1.6
1.2
u/ml
2.8
3.5
0.21
20
70
(3044242) Glucose [Moles/volume] in Arterial blood
9
55
1.64
0.73
1.3
2.9
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
31
401
0.77
0.73
1.6
1.4
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
5
25
2.00
0.72
1.0
1.3
mmol/l
-0.5
2.3
—
5
25
(1617658) Protocol used for examination of sentinel lymph nodes
6
106
0.56
0.72
1.0
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
13
195
0.66
0.72
2.7
2.9
mmol/l
6.0
7.3
1.63
13
190
(40761535) Cells panel - Urine sediment
78
911
0.85
0.71
3.6
3.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
7
40
1.75
0.71
1.0
1.1
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
5
26
1.93
0.70
1.4
1.0
—
82.6
—
0
5
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
252
2324
1.10
0.70
1.5
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
49
400
1.23
0.70
1.2
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
18
251
0.71
0.69
1.0
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
17
118
1.45
0.69
1.2
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
12
77
1.56
0.68
1.3
1.1
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
5
27
1.85
0.68
1.4
1.1
—
87.5
—
0
6
(21494890) Protein electrophoresis panel - 24 hour Urine
15
102
1.47
0.67
1.5
2.3
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
56
466
1.21
0.67
3.7
2.5
%
0.7
0.7
0.16
56
453
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1188
12117
0.93
0.67
5.3
4.9
mmol/mol
38.6
38.9
0.55
1109
11408
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
43
1.63
0.67
1.9
1.9
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
7
44
1.59
0.65
1.7
2.5
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
10
62
1.62
0.65
1.1
1.0
iu/ml
190.8
210.8
—
10
62
(3003888) Timothy IgE Ab [Units/volume] in Serum
24
314
0.76
0.63
1.1
1.1
u/ml
9.1
5.3
0.39
14
163
(4281824)
17
121
1.41
0.62
1.2
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
109
1225
0.88
0.61
1.8
2.0
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
38
307
1.24
0.61
1.7
1.3
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
51
1.57
0.60
1.0
1.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
207
2242
0.91
0.60
2.0
2.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
8
52
1.54
0.59
1.0
1.1
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
22
0.00
0.59
0.0
1.5
—
—
—
0
0
(4094501)
42
345
1.22
0.59
1.1
1.1
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
299
0.77
0.59
1.1
1.1
u/ml
1.1
1.6
0.32
11
123
(4010399)
73
840
0.86
0.58
1.7
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
19
140
1.36
0.58
1.2
1.1
—
—
—
0
0
(44806420)
0
23
0.00
0.58
0.0
2.5
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
23
0.00
0.58
0.0
1.3
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
6
35
1.72
0.57
1.3
1.3
ug/l
12.9
8.6
—
6
35
(3005570) Glucose [Moles/volume] in Urine
8
124
0.64
0.54
1.3
2.1
—
—
—
0
0
(4146454)
16
116
1.38
0.54
2.2
2.7
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
60
1.50
0.54
2.1
1.6
—
—
—
0
0
(4024509)
14
99
1.42
0.54
1.1
1.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
11
74
1.49
0.53
7.8
7.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
40
1.50
0.51
3.5
3.0
—
—
—
0
0
(3024263) Appearance of Synovial fluid
9
64
1.41
0.51
1.6
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
59
509
1.17
0.51
3.0
3.4
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
41
1.47
0.50
1.5
2.3
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
13
93
1.40
0.48
1.0
1.0
u/ml
13.3
1.2
—
7
27
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
27
217
1.25
0.48
1.1
1.1
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
54
466
1.16
0.47
2.2
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
581
5611
1.05
0.47
2.7
2.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
18
137
1.32
0.47
1.1
1.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
20
155
1.29
0.47
4.9
2.7
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
16
120
1.34
0.46
1.0
1.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
27
331
0.81
0.46
1.5
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
7
49
1.43
0.46
1.0
1.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
5
83
0.60
0.45
3.4
7.8
—
126.7
—
0
29
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
29
237
1.23
0.45
1.6
1.2
u/ml
3.1
5.4
0.84
22
98
(3006442) Creatine [Moles/volume] in Serum or Plasma
15
112
1.34
0.44
2.7
1.3
—
67.0
—
0
13
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
16
208
0.77
0.44
1.4
1.3
mmol/l
7.9
7.2
0.33
11
145
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
189
2021
0.93
0.43
2.0
2.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
95
1.37
0.43
1.2
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
87
1.38
0.42
2.0
2.1
%
11.2
11.3
0.02
12
87
(3019060) Gas panel - Arterial blood
76
680
1.12
0.42
5.0
5.3
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
15
0.00
0.41
0.0
2.1
—
—
—
0
0
(3042552) Rheumatoid factor [Units/volume] in Pleural fluid
0
15
0.00
0.41
0.0
1.0
—
10.2
—
0
6
(3051101) Glucose [Moles/volume] in Cord blood
0
15
0.00
0.41
0.0
5.4
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
59
1.36
0.41
1.1
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
86
949
0.90
0.40
1.5
1.9
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
18
0.00
0.40
0.0
3.8
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
9.4
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
0
18
0.00
0.40
0.0
1.2
—
57.9
—
0
5
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
8
61
1.31
0.39
1.0
1.1
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
5
35
1.43
0.39
1.8
2.2
—
—
—
0
0
(4133840)
5
35
1.43
0.39
1.8
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
19
0.00
0.39
0.0
3.9
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
29
243
1.20
0.37
1.1
1.1
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
56
496
1.13
0.37
1.6
1.5
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
17
213
0.80
0.37
2.5
2.8
mmol/l
1.2
1.5
1.36
17
204
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
9
124
0.72
0.35
1.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
6
43
1.40
0.35
1.2
2.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
91
1.32
0.33
1.2
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
17
208
0.82
0.31
1.4
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
47
419
1.13
0.30
2.2
1.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
7
55
1.27
0.30
2.4
3.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
13
102
1.28
0.30
1.1
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
12
93
1.29
0.30
1.0
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
83
893
0.93
0.26
1.6
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
392
4032
0.96
0.25
4.1
4.1
ug/l
1.9
2.1
0.88
357
3664
(3027944) Amphetamines [Presence] in Urine
85
792
1.08
0.25
1.5
2.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
40
359
1.12
0.24
1.7
1.9
iu/l
3.8
4.7
0.35
20
129
(3015183) Erythrocyte sedimentation rate
12
96
1.25
0.24
1.1
1.2
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
85
0.70
0.24
1.2
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
44
399
1.11
0.23
1.1
1.1
u/ml
13.4
4.4
—
5
66
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
16
134
1.20
0.23
5.6
4.5
u/ml
12.7
116.2
—
6
40
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
83
885
0.93
0.22
1.2
1.3
au/ml
52.1
44.0
—
5
43
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
91
967
0.94
0.22
2.1
2.4
au/ml
36.2
24.2
—
7
72
(40765096) Chromosome analysis panel by Banding
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
5
42
1.19
0.21
1.0
1.2
%
—
25.7
—
0
6
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
10
0.00
0.21
0.0
4.4
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
10
0.00
0.21
0.0
2.4
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
36.3
—
0
12
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
12
0.00
0.21
0.0
2.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
8
101
0.79
0.21
1.1
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
10
80
1.25
0.20
1.1
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
2.7
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
6
49
1.23
0.20
1.2
1.1
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
85
802
1.06
0.19
1.6
2.3
—
—
—
0
0
(1002224) Polysomnography panel
78
734
1.07
0.19
1.0
1.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
6
53
1.13
0.18
1.7
1.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
31
342
0.90
0.18
1.1
1.1
u/ml
0.3
1.9
2.38
12
142
(3028707) Methadone [Presence] in Urine by Screen method
31
342
0.90
0.18
1.7
3.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
73
689
1.06
0.17
1.8
1.6
mu/l
292.6
288.9
0.05
64
627
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
10
82
1.22
0.17
1.0
1.1
u/ml
—
12.7
—
0
6
(3041806) Other cells [#/volume] in Blood by Manual count
5
69
0.72
0.17
2.4
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
70
0.71
0.16
1.6
1.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
8
70
1.14
0.16
1.0
1.5
%
—
67.3
—
0
11
(3027008) Opiates [Presence] in Urine
85
808
1.05
0.16
1.5
2.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
9
78
1.15
0.15
1.1
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
85
810
1.05
0.15
1.6
2.3
—
—
—
0
0
(3036603) Volume of Urine
9
82
1.10
0.15
1.7
1.5
—
1781.3
—
0
13
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
35
378
0.92
0.14
1.9
1.7
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
10
118
0.85
0.14
1.3
1.5
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
99
0.81
0.13
1.0
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
33
356
0.93
0.13
6.4
6.3
mmol/l
1.5
1.2
0.38
28
310
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
9
106
0.85
0.13
1.1
1.5
mmol/l
2.1
1.9
—
9
99
(4027681)
9
107
0.84
0.13
1.1
1.3
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
16
142
1.13
0.12
1.1
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
10
85
1.18
0.12
1.1
1.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
99
1027
0.96
0.12
1.2
1.2
iu/ml
108.0
138.2
0.52
29
406
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
32
344
0.93
0.12
1.1
1.3
mg/l
486.1
518.7
0.12
32
324
(3016879) Cocaine [Presence] in Urine
78
748
1.04
0.12
1.5
2.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
12
105
1.14
0.11
1.1
2.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
33
309
1.07
0.10
1.4
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
57
545
1.05
0.10
1.7
3.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
66
634
1.04
0.10
1.5
2.3
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
25
232
1.08
0.09
1.0
1.1
u/ml
3.1
4.2
—
9
95
(44813793)
12
106
1.13
0.09
1.0
1.0
—
—
—
0
0
(3019225) pH of Specimen
112
1090
1.03
0.09
5.0
3.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
24
224
1.07
0.08
1.3
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
66
1.06
0.08
1.1
2.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
82
0.85
0.07
1.3
1.6
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
7
83
0.84
0.07
1.0
1.5
u/l
5.3
6.7
—
7
67
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
11
122
0.90
0.07
1.2
1.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
405
4012
1.01
0.07
1.6
1.5
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
9
87
1.03
0.07
1.2
1.2
—
1.8
—
0
5
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
111
0.90
0.06
1.7
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
29
276
1.05
0.06
1.7
1.6
e6/l
6196.7
9952.6
0.60
22
208
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
10
90
1.11
0.05
1.4
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
15
139
1.08
0.05
1.4
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
30
287
1.05
0.05
1.4
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
40
414
0.97
0.05
4.1
3.5
g/l
0.2
0.2
1.11
21
181
(3044941) Cell count panel - Synovial fluid
20
189
1.06
0.04
1.5
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
13
140
0.93
0.04
1.4
1.5
mmol/l
8.8
13.4
—
6
33
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
78
766
1.02
0.03
2.4
2.8
ng/l
217.3
159.6
0.35
68
681
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
24
230
1.04
0.03
1.1
1.1
iu/ml
41.0
2100.1
—
6
63
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
53
518
1.02
0.03
1.7
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
163
1645
0.99
0.03
1.6
1.8
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
22
211
1.04
0.03
1.5
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
94
950
0.99
0.02
1.6
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
30
293
1.02
0.01
3.0
2.4
ug/min
41.1
136.3
2.27
20
183
(3010726) Horse dander IgE Ab [Units/volume] in Serum
29
297
0.98
0.01
1.1
1.1
u/ml
1.3
2.2
—
8
73
(3032773) Endomysium IgG Ab [Titer] in Serum
13
124
1.05
0.00
1.0
1.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
23
236
0.97
0.00
1.1
1.1
u/ml
1.1
2.6
—
6
115
(3020191) Ethanol [Moles/volume] in Serum or Plasma
12
116
1.03
0.00
3.6
1.6
promille
1.1
1.4
—
7
95
(3004616) Nuclear Ab [Presence] in Serum
15
154
0.97
0.00
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
28
284
0.99
0.00
1.0
1.5
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
11
112
0.98
0.00
1.2
1.4
g/l
36.1
32.5
0.64
11
93
(3045424) Erythrocytes [Presence] in Urine
24
239
1.00
0.00
1.3
1.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
30
301
1.00
0.00
1.1
1.5
e6/l
53.8
2253.4
1.38
24
244
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
30
301
1.00
0.00
1.0
1.4
e6/l
22.3
18.9
0.09
22
235
(3014133) Dog dander IgE Ab [Units/volume] in Serum
26
257
1.01
0.00
1.1
1.1
u/ml
2.3
3.1
—
9
96
(44806118)
15
145
1.03
0.00
1.8
1.7
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
25
255
0.98
0.00
1.8
1.7
—
—
—
0
0
(44790047)
15
145
1.03
0.00
1.8
1.7
—
—
—
0
0
(44790049)
15
145
1.03
0.00
1.8
1.7
—
—
—
0
0
(44790048)
15
145
1.03
0.00
1.8
1.7
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
10
105
0.95
0.00
3.1
2.4
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
1765.2
—
0
5
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4212803)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
12.1
—
0
9
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
7
0.00
0.00
0.0
4.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.7
—
2.4
—
0
6
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
5.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
5
55
0.91
0.00
1.4
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
9
92
0.98
0.00
1.2
1.5
—
—
—
0
0
(3000936) Kiwifruit IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1.1
—
0
5
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
9
94
0.96
0.00
1.2
1.1
—
103.0
—
0
7
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
9
94
0.96
0.00
1.2
1.2
—
73.9
—
0
8
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
9
92
0.98
0.00
1.2
1.1
—
43.2
—
0
5
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
72
0.97
0.00
1.3
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint ULCERILEO and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ULCERILEO | 1.556 [1.35, 1.8] | < 0.001 |
| Birth year | 0.994 [0.98, 1.0] | 0.237 |
During the follow-up period (1.1.1998 — 31.12.2019), 348 out of 3374 females with ULCERILEO died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| ULCERILEO | 1.401 [1.24, 1.58] | < 0.001 |
| Birth year | 0.987 [0.98, 1.0] | 0.008 |
During the follow-up period (1.1.1998 — 31.12.2019), 558 out of 4020 males with ULCERILEO died.
Mortality risk
Mortality risk for people of age
years, who have ULCERILEO.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.146% | 0.272% |
| 5 | 0.768% | 1.692% |
| 10 | 2.104% | 4.381% |
| 15 | 4.226% | 8.036% |
| 20 | 7.32% | 12.983% |
Relationships between endpoints
↥Index endpoint: ULCERILEO – Ulcerative ileocolitis
GWS hits: 4
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data